Holen Sie sich die Stockscreener-App
50.14
2.24%
-1.26
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Hims & Hers Stock Surges On Strong Q1 Results, Falls After Convertible Note Offering - Benzinga
Hims & Hers Announces $450M Convertible Notes Offering - TipRanks
Hims & Hers Health prices upsized $870M convertible senior notes - MSN
Hims & Hers (HIMS) Doubles Down on AI & Global Growth with $870M Boost - TipRanks
Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare - 01net
Hims CEO Rides Weight-Loss Drug Boom to $1.1 Billion Fortune - MSN
Hims & Hers (NYSE: HIMS) Earnings Are In (Live Coverage) - MSN
Hims & Hers Stock's 100% Surge Is Squeezing Shorts And It Might Just Be Getting Started - Benzinga
Hims & Hers names Amazon veteran as COO - Healthcare Dive
Hims & Hers hires former Amazon exec as Q1 revenue doubles - Retail Dive
Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer - 01net
Hims & Hers: The Road To Blue Chip Status (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Stock Is Sliding Thursday: What's Going On? - Benzinga
Hims & Hers Health to offer $450M convertible senior notes - MSN
Hims & Hers plans $450M convertible notes offering By Investing.com - Investing.com Canada
Hims & Hers shares fall on convertible notes offering By Investing.com - Investing.com Canada
Hims & Hers shares fall on convertible notes offering - Investing.com
Hims & Hers plans $450M convertible notes offering - Investing.com
Hims & Hers Soars Again--Explosive Growth Meets Lofty Expectations (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare - Bluefield Daily Telegraph
After Leaping 89% Hims & Hers Health, Inc. (NYSE:HIMS) Shares Are Not Flying Under The Radar - simplywall.st
Hims & Hers appoints Mo Elshenawy as CTO to boost AI healthcare - Investing.com
Hims & Hers Has a Superpower in Healthcare - Nasdaq
Superb Quarterly Report Opens Door to $100 Price Target on Hims & Hers Health Stock (HIMS) - TipRanks
How much a $1,000 investment in Hims & Hers at its IPO would be worth now - MSN
Hims & Hers Health Shocks Investors With a Long-Term Forecast, but Is the Stock a Buy? - The Motley Fool
Cofounder Of Hims, Seller Of Hair Loss And Erectile Dysfunction Pills, Is A Billionaire After Weight Loss Drug Deal - Forbes
Hims & Hers: 2030 Guidance Indicates Big Upside (NYSE:HIMS) - Seeking Alpha
Hims & Hers Stock Soars 32% Since Tuesday On Strong Q1 Earnings And Robust Outlook - Benzinga
Surging Earnings Estimates Signal Upside for Hims & Hers Health (HIMS) Stock - Nasdaq
Hims & Hers: Short Squeeze Or Strong Fundamentals? (Rating Downgrade) (NYSE:HIMS) - Seeking Alpha
Hims & Hers Shows It's More Than Just GLP-1 Drugs - 24/7 Wall St.
Hims & Hers Health Inc. (HIMS) Stock: Monster Q1 Growth Can't Save Stock from After-Hours Tumble - CoinCentral
Hims & Hers Health, Inc. (NYSE:HIMS) Q1 2025 Earnings Call Transcript - MSN
Hims & Hers Health: Healthcare Disruptor Building A Durable Moat (Initiate With Buy) - Seeking Alpha
Hims & Hers Health First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Why Hims & Hers Health, Inc. (HIMS) Skyrocketed On Tuesday - Insider Monkey
Hims & Hers Stock (HIMS) Falls as Cautious Outlook Blurs Massive Revenue Growth - Yahoo Finance
What's Next For HIMS Stock After An Upbeat Q1? - Nasdaq
This Week's Healthcare Earnings: Moderna, CVS, Hims & Hers - Law360
Hims & Hers Health, Inc. Reports Strong Q1 Earnings - TipRanks
Piper Sandler Raises Price Target for Hims & Hers Health (HIMS) to $39.00 | HIMS Stock News - GuruFocus
Hims & Hers Health (HIMS) Surges 18.12%: What’s Fueling the Rally? - Wealth Daily
Stock Movers: Palantir, Hims, Constellation Energy - Bloomberg.com
What’s driving the roller coaster ride for San Francisco’s Hims & Hers stock? - San Francisco Chronicle
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why - Yahoo Finance
Palantir, Tesla, Ford, Constellation Energy, SolarEdge, Vertex, DoorDash, and More Movers - Barron's
Wall Street Punishes HIMS--Right After It Lands a Blockbuster Weight Loss Deal - Yahoo Finance
Noteworthy Tuesday Option Activity: ROOT, HIMS, SN - Nasdaq
Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped - Nasdaq
2 Reasons Hims & Hers Will Break $50sBuy Post Earnings (NYSE:HIMS) - Seeking Alpha
HIMS Q1 Earnings Call: Personalized Care and New Partnerships Drive Upside, Guidance Signals Near-Term Transition - Yahoo Finance
HIMS Stock Dips Pre-Market Despite Q1 Earnings Beat, Gross Margin Down - Yahoo Finance
Hims & Hers Health (HIMS) Price Target Raised by Citigroup | HIMS Stock News - GuruFocus
Hims surges, SolarEdge earnings beat, Rivian expands in Illinois - Yahoo Finance
Hims & Hers stock jumps after blowout quarter, long-term guidance stuns Street - Proactive financial news
Hims & Hers Stock Rises on Fundamentals and Squeeze Potential - MarketBeat
What's Going On With Hims & Hers Stock Tuesday? - Benzinga
Hims & Hers Q1 2025 slides: Sets $6.5B revenue target for 2030 amid specialty expansion - Investing.com
Hims & Hers Health Faces Strategic Choice Between Semaglutide Expansion or Core Business, BofA Says - marketscreener.com
1.45%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):